OneSpan Inc vs Tilray Brands Inc — how do they compare? OneSpan Inc trades at $18.22 (market cap $662.97M), while Tilray Brands Inc trades at $3.54 (market cap $530.54M). The key difference: OneSpan Inc is the larger of the two by market cap, and OneSpan Inc pays a 2.89% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold OneSpan Inc for 18 Days and Tilray Brands Inc for 31 Days on average.
| OSPN | TLRY | |
|---|---|---|
Market Cap | $662.97M | $530.54M |
Volume | 616,882 | 9,099,075 |
Sector | Technology | Health |
52-Week High | $18.42 | $17.20 |
52-Week Low | $10.15 | $3.54 |
Typical Hold Time | 18 Days | 31 Days |
Enterprise Value | $632.05M | $684.46M |
Dividend Yield | 2.89% | — |
Signals from Pluang's Aura AI — not financial advice
OneSpan (OSPN) trades at $18.01, up 1.75% with strong technical momentum and bullish moving averages. The company demonstrates robust fundamentals with a 27.76% net margin and consistent earnings beats, though 2026 projections show slight margin compression. Recent product innovation with DigipassONE and institutional interest from Deutsche Bank highlight growth potential amid competitive pressures.
Outlook remains positive with 67% analyst buy ratings and attractive valuation at 10.16 P/E, but investors face risks from subscription transition execution and market volatility. The stock's current technical positioning near key resistance at $19 requires monitoring for breakout confirmation.
Tilray Brands (TLRY) trades at $3.59, down 3.36% on the day and near 52-week lows, with bearish technical indicators dominating. The company reported $821 million in revenue for 2025 but posted a massive $2.19 billion net loss due to impairment charges. Recent earnings have consistently missed expectations, though analyst consensus remains cautiously optimistic with a $65.01 price target. The stock faces significant headwinds from ongoing profitability challenges and cannabis industry volatility.
TLRY presents a high-risk opportunity with potential upside if management can achieve profitability and capitalize on cannabis reform catalysts. However, persistent losses, negative cash flow, and competitive pressures create substantial downside risk. Investors should weigh the speculative nature against potential regulatory catalysts in the coming months.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
OneSpan Inc. is a global leader in providing digital agreement security solutions. The company's platform helps organizations, primarily in the financial services sector, to secure their digital agreements and transactions, including e-signatures, multi-factor authentication, and transaction monitoring. OneSpan's technology is focused on protecting customers from fraud and meeting regulatory compliance requirements in a digital-first environment.
Read more on OSPN →Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →